Review
Open access
Sep 2026
Omalizumab for pediatric allergic asthma: evidence-based insights on efficacy and safety from a meta-analysis of randomized trials
Objectives This meta-analysis aimed to synthesize data from English-language randomized controlled trials (RCTs) to evaluate the efficacy and safety of omalizumab in patients aged 6–20 years with allergic asthma, with specific attention to age-stratified outcomes where feasible. Methods Conducted in accordance with the...
Jin-Biao Han, Zhuan Zou, Shan-Shan Wu et al.
· Frontiers in Pharmacology · 0 citations